Real-time enrollment status for this hurthle cell thyroid cancer clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 10:21 PM UTC
| NCT Number | NCT00001160 |
| Recruiting Status | Recruiting |
| Condition | Hurthle Cell Thyroid Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 2,500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Last Updated on CT.gov | August 27, 2026 (3 days ago) |
As of August 30, 2026: Clinical trial NCT00001160 is currently recruiting participants. This clinical trial study for hurthle cell thyroid cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00001160 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00001160 was last updated 3 days ago (August 27, 2026). HelloStudys verifies this status automatically.